Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Scott D Nelson
Affiliation
University of California-Los Angeles
ORCID
Career Start Year
1990
Papers
152
H Index
35
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36402606
Use of neoadjuvant pexidartinib with limb salvage surgery for diffuse tenosynovial giant cell tumor: A case report.
J Orthop Sci
2024
36123403
Label-free intraoperative histology of bone tissue via deep-learning-assisted ultraviolet photoacoustic microscopy.
Nat Biomed Eng
2023
37292676
The landscape of drug sensitivity and resistance in sarcoma.
bioRxiv
2023
37146173
FAPI PET Signal in Hibernoma Reflects FAP Expression in Tumor Vasculature Cells.
Clin Nucl Med
2023
37333052
Fibroblast Activation Protein Expression in Sarcomas.
Sarcoma
2023
36581724
Lifelong Imaging Surveillance is Indicated for Patients with Primary Retroperitoneal Liposarcoma.
Ann Surg Oncol
2023
36690841
ASO Visual Abstract: Lifelong Imaging Surveillance is Indicated for Patients with Primary Retroperitoneal Liposarcoma.
Ann Surg Oncol
2023
35025671
Electronic Health Record-Integrated Tumor Board Application to Save Preparation Time and Reduce Errors.
JCO Clin Cancer Inform
2022
35307963
Retrospective analysis of adjuvant treatment for localized, operable uterine leiomyosarcoma.
Cancer Med
2022
35171675
Personalized chordoma organoids for drug discovery studies.
Sci Adv
2022
34115928
T-LAK cell-originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma.
Mol Oncol
2021
33908045
Prediction of soft tissue sarcoma response to radiotherapy using longitudinal diffusion MRI and a deep neural network with generative adversarial network-based data augmentation.
Med Phys
2021
33532938
Limitations of dual-energy CT in the detection of monosodium urate deposition in dense liquid tophi and calcified tophi.
Skeletal Radiol
2021
34484648
Aggressive osteoblastoma with a secondary aneurysmal bone cyst treated with denosumab.
Rare Tumors
2021
34767468
Establishment and Characterization of a Novel Dedifferentiated Chondrosarcoma Cell Line DDCS2.
Cancer Control
2021
34118584
Wide en bloc resection of an extraskeletal myxoid chondrosarcoma about the knee with single-stage knee extensor mechanism reconstruction: A case report.
Knee
2021
32345663
A Novel Anionic-phosphate-platinum Complex Effectively Targets a Cisplatinum-resistant Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse Model.
Cancer Genomics Proteomics
2020
32054730
A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma.
Clin Cancer Res
2020
31639427
Patient-derived orthotopic xenograft models of sarcoma.
Cancer Lett
2020
31896528
Exquisite Tumor Targeting by Salmonella A1-R in Combination with Caffeine and Valproic Acid Regresses an Adult Pleomorphic Rhabdomyosarcoma Patient-Derived Orthotopic Xenograft Mouse Model.
Transl Oncol
2020
31794912
Chimeric antigen receptor T (CAR-T) cell immunotherapy for sarcomas: From mechanisms to potential clinical applications.
Cancer Treat Rev
2020
31736134
Establishment and Characterization of a Recurrent Osteosarcoma Cell Line: OSA 1777.
J Orthop Res
2020
33344320
Exogenous Ochronosis (EO): Skin lightening cream causing rare caviar-like lesion with banana-like pigments; review of literature and histological comparison with endogenous counterpart.
Autops Case Rep
2020
33303744
Evading the host response: Staphylococcus "hiding" in cortical bone canalicular system causes increased bacterial burden.
Bone Res
2020
32691223
Cyclin-dependent kinase 12 (CDK12) in chordoma: prognostic and therapeutic value.
Eur Spine J
2020
32960500
T-LAK cell-originated protein kinase (TOPK) is a Novel Prognostic and Therapeutic Target in Chordoma.
Cell Prolif
2020
32846908
Chemotherapy and Survival in Patients with Primary High-Grade Extremity and Trunk Soft Tissue Sarcoma.
Cancers (Basel)
2020
32755981
Low Rates of Chemotherapy Use for Primary, High-Grade Soft Tissue Sarcoma: A National Cancer Database Analysis.
J Natl Compr Canc Netw
2020
32366396
Recombinant Methioninase Combined With Tumor-targeting <i>Salmonella typhimurium</i> A1-R Induced Regression in a PDOX Mouse Model of Doxorubicin-resistant Dedifferentiated Liposarcoma.
Anticancer Res
2020
32554891
Treatment effect prediction for sarcoma patients treated with preoperative radiotherapy using radiomics features from longitudinal diffusion-weighted MRIs.
Phys Med Biol
2020
30660363
Gemcitabine combined with docetaxel precisely regressed a recurrent leiomyosarcoma peritoneal metastasis in a patient-derived orthotopic xenograft (PDOX) model.
Biochem Biophys Res Commun
2019
31687646
Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases.
JBMR Plus
2019
30024282
Patterns of sensitivity to a panel of drugs are highly individualised for undifferentiated/unclassified soft tissue sarcoma (USTS) in patient-derived orthotopic xenograft (PDOX) nude-mouse models.
J Drug Target
2019
31616697
Glomus tumor of uncertain malignant potential of the brachial plexus: A case report.
World J Clin Cases
2019
31329901
CT Fat Density Accurately Reflects Histologic Fat Quality in Adults With HIV On and Off Antiretroviral Therapy.
J Clin Endocrinol Metab
2019
31528627
Primary pulmonary undifferentiated pleomorphic sarcoma (PPUPS).
Autops Case Rep
2019
31436746
Oncologic Accuracy of Image-guided Percutaneous Core-Needle Biopsy of Peripheral Nerve Sheath Tumors at a High-volume Sarcoma Center.
Am J Clin Oncol
2019
31519578
Eribulin Suppressed Cisplatinum- and Doxorubicin-resistant Recurrent Lung Metastatic Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse Model.
Anticancer Res
2019
31200257
The combination of gemcitabine and docetaxel arrests a doxorubicin-resistant dedifferentiated liposarcoma in a patient-derived orthotopic xenograft model.
Biomed Pharmacother
2019
30775238
Advances in immune checkpoint inhibitors for bone sarcoma therapy.
J Bone Oncol
2019
30807865
A patient-derived orthotopic xenograft (PDOX) nude-mouse model precisely identifies effective and ineffective therapies for recurrent leiomyosarcoma.
Pharmacol Res
2019
30913092
Pathologic Response to Neoadjuvant Therapy is Associated With Improved Long-term Survival in High-risk Primary Localized Malignant Peripheral Nerve Sheath Tumors.
Am J Clin Oncol
2019
30758647
Regorafenib regressed a doxorubicin-resistant Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude mouse model.
Cancer Chemother Pharmacol
2019
31133242
Temozolomide targets and arrests a doxorubicin-resistant follicular dendritic-cell sarcoma patient-derived orthotopic xenograft mouse model.
Tissue Cell
2019
31133237
Pazopanib regresses a doxorubicin-resistant synovial sarcoma in a patient-derived orthotopic xenograft mouse model.
Tissue Cell
2019
30521959
Epithelioid Osteoblastoma of the Temporal Bone: A Case Report.
World Neurosurg
2019
30591443
Detection of Metastasis in a Patient-derived Orthotopic Xenograft (PDOX) Model of Undifferentiated Pleomorphic Sarcoma with Red Fluorescent Protein.
Anticancer Res
2019
30616082
The combination of gemcitabine and nab-paclitaxel as a novel effective treatment strategy for undifferentiated soft-tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.
Biomed Pharmacother
2019
28640064
Predictors of Local Recurrence in Patients With Myxofibrosarcoma.
Am J Clin Oncol
2018
30166061
Combination therapy of tumor-targeting Salmonella typhimurium A1-R and oral recombinant methioninase regresses a BRAF-V600E-negative melanoma.
Biochem Biophys Res Commun
2018
1 - 50 of 152
Column Actions
Search
Recommended Authors
Julio A Diaz-Perez
12235University of Miami Miller School of Medicine
Career Start Year
2007
Number of shared co-authors
0
Christian F Meyer
Johns Hopkins University School of Medicine
Career Start Year
2005
Number of shared co-authors
2
Bernadette Liegl-Atzwanger
Diagnostic and Research Institute of Pathology, Medical University of Graz
Career Start Year
2003
Number of shared co-authors
2
Sandra J Strauss
University College London, Cancer Institute
Career Start Year
2003
Number of shared co-authors
0
Carol D Morris
The Johns Hopkins Hospital
Career Start Year
2001
Number of shared co-authors
2
Chantal Pauli
University Hospital Zurich
Career Start Year
2001
Number of shared co-authors
1
Sung Wook Seo
Samsung Medical Center, Sungkyunkwan University
Career Start Year
2001
Number of shared co-authors
0
Nasir Ud Din
Department of Pathology and Laboratory Medicine Aga Khan University Hospital Karachi
Career Start Year
2001
Number of shared co-authors
1
Abbas Agaimy
Institute of Pathology, Friedrich-Alexander University Erlangen-Nurnberg (FAU)
Career Start Year
2000
Number of shared co-authors
1
Elizabeth G Demicco
Mount Sinai Hospital and Laboratory Medicine and Pathobiology, University of Toronto
Career Start Year
2000
Number of shared co-authors
1
Gyeongsin Park
Seoul St. Mary's Hospital, The Catholic University of Korea
Career Start Year
1999
Number of shared co-authors
0
Andreas Leithner
Medical University of Graz
Career Start Year
1998
Number of shared co-authors
2
Bret Wehrli
Schulich School of Medicine & Dentistry, Western University
Career Start Year
1998
Number of shared co-authors
1
Brendan C Dickson
Mount Sinai Hospital and Laboratory Medicine and Pathobiology, University of Toronto
Career Start Year
1997
Number of shared co-authors
3
Fernanda Amary
Royal National Orthopaedic Hospital
Career Start Year
1997
Number of shared co-authors
1
Gonzague de Pinieux
University Hospital of Tours
Career Start Year
1996
Number of shared co-authors
0
Atiya Mansoor
Oregon Health & Science University
Career Start Year
1996
Number of shared co-authors
0
Brian P Rubin
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Career Start Year
1994
Number of shared co-authors
3
Rebecca A Gladdy
Mount Sinai Hospital
Career Start Year
1994
Number of shared co-authors
1
Roberto Tirabosco
University College London, UCL Cancer Institute
Career Start Year
1994
Number of shared co-authors
1
John M Kane
Roswell Park Comprehensive Cancer Center
Career Start Year
1993
Number of shared co-authors
2
Jason L Hornick
Brigham and Women's Hospital and Harvard Medical School
Career Start Year
1993
Number of shared co-authors
2
Jay S Wunder
University of Toronto
Career Start Year
1990
Number of shared co-authors
3
Alexander J Lazar
The University of Texas MD Anderson Cancer Center
Career Start Year
1989
Number of shared co-authors
4
Adrienne M Flanagan
University College London, UCL Cancer Institute
Career Start Year
1987
Number of shared co-authors
2
Ossama Tawfik
University of Kansas
Career Start Year
1985
Number of shared co-authors
0
Cyril Fisher
University Hospitals Birmingham NHS Foundation Trust
Career Start Year
1984
Number of shared co-authors
1
Rex C Bentley
Duke School of Medicine
Career Start Year
1984
Number of shared co-authors
0
Raphael E Pollock
James Cancer Center, The Ohio State University
Career Start Year
1984
Number of shared co-authors
6
Piero Picci
IRCCS Istituto Ortopedico Rizzoli
Career Start Year
1979
Number of shared co-authors
3
row(s) 1 - 30 of 30
Collaborators
Fritz C Eilber
University of California, Los Angeles David Geffen School of Medicine
Co-authored papers
72
Arun S Singh
University of California-Los Angeles
Co-authored papers
55
Robert M Hoffman
Co-authored papers
54
Sarah M Dry
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers
54
Bartosz Chmielowski
Jonsson Comprehensive Cancer Center, University of California Los Angeles
Co-authored papers
25
Noah Federman
University of California los angeles
Co-authored papers
18
Frederick R Eilber
University of California-Los Angeles
Co-authored papers
17
Nicholas M Bernthal
University of California-Los Angeles
Co-authored papers
17
Anusha Kalbasi
Stanford Cancer Institute, Stanford School of Medicine
Co-authored papers
12
Michael Bouvet
Co-authored papers
11
Francis J Hornicek
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Co-authored papers
10
Joseph G Crompton
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers
6
Jane Yanagawa
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers
6
Susan V Bukata
University of California
Co-authored papers
5
Mitchell Kamrava
Cedars Sinai Medical Center
Co-authored papers
5
Michael L Steinberg
University of California los angeles
Co-authored papers
5
Yingli Yang
Ruijin Hospital
Co-authored papers
3
Johannes Czernin
university of california los angeles
Co-authored papers
3
Dan Ruan
Zhongshan Hospital, Fudan University
Co-authored papers
3
Jomjit Chantharasamee
Siriraj Hospital, Mahidol University
Co-authored papers
3
David Elashoff
David Geffen School of Medicine at University of California los angeles
Co-authored papers
3
Robert B Cameron
University of California los angeles
Co-authored papers
3
Christopher P Cannon
Brigham and Women's Hospital
Co-authored papers
2
Peng Hu
University of Pennsylvania
Co-authored papers
2
Jeremie Calais
university of california los angeles
Co-authored papers
2
Alice Soragni
David Geffen School of Medicine, University of California los angeles
Co-authored papers
2
Nasrin Tavanaie
David Geffen School of Medicine, University of California los angeles
Co-authored papers
2
Yu Gao
University of California los angeles
Co-authored papers
2
Mai Nguyen
University of California Riverside
Co-authored papers
2
Thinzar M Lwin
City of Hope National Medical Center
Co-authored papers
2
1 - 30